These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31474191)

  • 1. Anti-IFNAR treatment does not reverse neuropsychiatric disease in MRL/
    Huang MW; Stock AD; Mike EV; Herlitz L; Kolbeck R; Putterman C
    Lupus; 2019 Nov; 28(13):1510-1523. PubMed ID: 31474191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway.
    Wen J; Xia Y; Stock A; Michaelson JS; Burkly LC; Gulinello M; Putterman C
    J Autoimmun; 2013 Jun; 43():44-54. PubMed ID: 23578591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling.
    Mike EV; Makinde HM; Der E; Stock A; Gulinello M; Gadhvi GT; Winter DR; Cuda CM; Putterman C
    Front Immunol; 2018; 9():2189. PubMed ID: 30319641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus.
    Wen J; Doerner J; Chalmers S; Stock A; Wang H; Gullinello M; Shlomchik MJ; Putterman C
    J Neuroinflammation; 2016 Apr; 13(1):73. PubMed ID: 27055816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL13 Neutralization Attenuates Neuropsychiatric Manifestations in Lupus-Prone Mice.
    Huang MW; Stock AD; Putterman C
    Front Immunol; 2021; 12():763065. PubMed ID: 34868008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An essential role for IFN-alpha in the overexpression of Fas ligand on MRL/lpr lymphocytes and on their spontaneous Fas-mediated cytotoxic potential.
    Hadj-Slimane R; Chelbi-Alix MK; Tovey MG; Bobé P
    J Interferon Cytokine Res; 2004 Dec; 24(12):717-28. PubMed ID: 15684739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue Kallikrein-1 Suppresses Type I Interferon Responses and Reduces Depressive-Like Behavior in the MRL/lpr Lupus-Prone Mouse Model.
    Bhoj PS; Nocito C; Togre NS; Winfield M; Lubinsky C; Khan S; Mogadala N; Seliga A; Unterwald EM; Persidsky Y; Sriram U
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral Deficits Are Accompanied by Immunological and Neurochemical Changes in a Mouse Model for Neuropsychiatric Lupus (NP-SLE).
    Li Y; Eskelund AR; Zhou H; Budac DP; Sánchez C; Gulinello M
    Int J Mol Sci; 2015 Jul; 16(7):15150-71. PubMed ID: 26151848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice.
    Stock AD; Wen J; Doerner J; Herlitz LC; Gulinello M; Putterman C
    J Neuroinflammation; 2015 Nov; 12():205. PubMed ID: 26546449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Centrally Acting Angiotensin-Converting Enzyme Inhibitor Suppresses Type I Interferon Responses and Decreases Inflammation in the Periphery and the CNS in Lupus-Prone Mice.
    Nocito C; Lubinsky C; Hand M; Khan S; Patel T; Seliga A; Winfield M; Zuluaga-Ramirez V; Fernandes N; Shi X; Unterwald EM; Persidsky Y; Sriram U
    Front Immunol; 2020; 11():573677. PubMed ID: 33042154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Th17-Associated Interstitial Kidney Inflammation in Lupus-Prone Mice Lacking the Gene Encoding STAT-1.
    Yiu G; Rasmussen TK; Ajami B; Haddon DJ; Chu AD; Tangsombatvisit S; Haynes WA; Diep V; Steinman L; Faix J; Utz PJ
    Arthritis Rheumatol; 2016 May; 68(5):1233-44. PubMed ID: 26636548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise alleviates symptoms of CNS lupus.
    Jacob A; Nina Peralta L; Pegues D; Okamura K; Chang A; McSkimming D; Alexander J
    Brain Res; 2021 Aug; 1765():147478. PubMed ID: 33852888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited preventive effect of prednisone on neuropsychiatric symptoms in murine systemic lupus erythematosus.
    Lu F; Lu H; Xie M; Li S; Zu Y; Zhou J; Yu J; Wang S; Ruan Y; Wen C; Xu Z
    Inflammopharmacology; 2019 Jun; 27(3):511-520. PubMed ID: 30911862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipocalin-2 drives neuropsychiatric and cutaneous disease in MRL/lpr mice.
    Garcia SJ; Mike EV; Zhang J; Cuda CM; Putterman C
    Front Immunol; 2024; 15():1466868. PubMed ID: 39399497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The T Cell Receptor Repertoire in Neuropsychiatric Systemic Lupus Erythematosus.
    Moore E; Huang MW; Jain S; Chalmers SA; Macian F; Putterman C
    Front Immunol; 2020; 11():1476. PubMed ID: 32765512
    [No Abstract]   [Full Text] [Related]  

  • 16. Type I IFN protects against murine lupus.
    Hron JD; Peng SL
    J Immunol; 2004 Aug; 173(3):2134-42. PubMed ID: 15265950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FTY720 attenuates behavioral deficits in a murine model of systemic lupus erythematosus.
    Shi D; Tian T; Yao S; Cao K; Zhu X; Zhang M; Wen S; Li L; Shi M; Zhou H
    Brain Behav Immun; 2018 May; 70():293-304. PubMed ID: 29548997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with lysophosphatidic acid prevents microglial activation and depression-like behaviours in a murine model of neuropsychiatric systemic lupus erythematosus.
    Nagata W; Koizumi A; Nakagawa K; Takahashi S; Gotoh M; Satoh Y; Ishizuka T
    Clin Exp Immunol; 2023 Apr; 212(2):81-92. PubMed ID: 36718978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of the type I interferon receptor protects mice from experimental lupus.
    Nacionales DC; Kelly-Scumpia KM; Lee PY; Weinstein JS; Lyons R; Sobel E; Satoh M; Reeves WH
    Arthritis Rheum; 2007 Nov; 56(11):3770-83. PubMed ID: 17968932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus.
    Chalmers SA; Wen J; Shum J; Doerner J; Herlitz L; Putterman C
    Clin Immunol; 2017 Dec; 185():100-108. PubMed ID: 27570219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.